Abstract

We report the characterisation of 27 cardiovascular-related traits in 23 inbred mouse strains. Mice were phenotyped either in response to chronic administration of a single dose of the β-adrenergic receptor blocker atenolol or under a low and a high dose of the β-agonist isoproterenol and compared to baseline condition. The robustness of our data is supported by high trait heritabilities (typically H2>0.7) and significant correlations of trait values measured in baseline condition with independent multistrain datasets of the Mouse Phenome Database. We then focused on the drug-, dose-, and strain-specific responses to β-stimulation and β-blockade of a selection of traits including heart rate, systolic blood pressure, cardiac weight indices, ECG parameters and body weight. Because of the wealth of data accumulated, we applied integrative analyses such as comprehensive bi-clustering to investigate the structure of the response across the different phenotypes, strains and experimental conditions. Information extracted from these analyses is discussed in terms of novelty and biological implications. For example, we observe that traits related to ventricular weight in most strains respond only to the high dose of isoproterenol, while heart rate and atrial weight are already affected by the low dose. Finally, we observe little concordance between strain similarity based on the phenotypes and genotypic relatedness computed from genomic SNP profiles. This indicates that cardiovascular phenotypes are unlikely to segregate according to global phylogeny, but rather be governed by smaller, local differences in the genetic architecture of the various strains.

Highlights

  • The b-adrenergic system controls cardiac contractility and excitability, heart rate and vascular tone

  • Pharmacological targeting of b-adrenergic receptors is a well documented first-line therapeutic approach for the management of cardiac arrhythmias, cardio-protection after myocardial infarction, and hypertension [1,2], while b-agonists are administered in cases of bradycardia, heart block or asthma [3,4]

  • One-way Analyses Of Variance (ANOVA) showed high reproducibility for all phenotypes measured under ctr or any given treatment

Read more

Summary

Introduction

The b-adrenergic system controls cardiac contractility and excitability, heart rate and vascular tone. Pharmacological targeting of b-adrenergic receptors is a well documented first-line therapeutic approach for the management of cardiac arrhythmias, cardio-protection after myocardial infarction, and hypertension [1,2], while b-agonists are administered in cases of bradycardia, heart block or asthma [3,4]. Iso is a classical badrenergic agonist that induces positive cardiac inotropy and chronotropy It is administered acutely in cases of bradycardia, heart block or pulmonary emergencies. In both humans and mice, ate is mainly eliminated unchanged by the kidneys and the faeces [7,8], while iso is metabolised within minutes post-administration into inactive metabolites by the liver catechol-O-methyltransferase (COMT) [9]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call